{"id":61261,"date":"2024-02-28T07:32:49","date_gmt":"2024-02-28T07:32:49","guid":{"rendered":"https:\/\/medsname.com\/vilano\/"},"modified":"2026-05-01T10:49:16","modified_gmt":"2026-05-01T10:49:16","slug":"vilano","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/vilano\/","title":{"rendered":"Vilano"},"content":{"rendered":"

<\/p>\n

\n

⚡ Quick Answer — What is Vilano?<\/h3>\n
\n

Vilano<\/strong> tartalmaz vilazodone 40 mg<\/strong> from a WHO-GMP certified manufacturer (Lupin Pharmaceuticals) — a dual-mechanism antidepressant<\/strong>: SERT inhibition (SSRI) K\u00fcl\u00f6nb\u00f6zik a depot injekci\u00f3?<\/em> 5-HT1A<\/sub> partial agonism. FDA-approved 2011 for MDD only<\/strong> (no anxiety or other indications). Standard target dose: 40 mg once daily with food<\/strong> (must be taken with at least 500 calories — bioavailability halves on an empty stomach). Titrate from 10 mg over 2 weeks to reduce GI side effects. Sexual side-effect rate is lower than other SSRIs<\/strong> — the 5-HT1A<\/sub> partial agonism is the proposed reason. Diarrhoea is the most common bothersome side effect. Onset 2–4 weeks; full response by 8 weeks.<\/p>\n<\/div>\n

\nMit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n

\ud83d\udce6 Minden rendel\u00e9st fedez a \u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n

Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n

Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n<\/div>\n

Important — this is not a situational-anxiety medication.<\/strong> Vilano is a SSRI plus 5-HT1A partial agonist<\/strong>, prescribed and titrated over weeks for nagy depresszi\u00f3s zavar (MDD)<\/strong>. It is nem<\/strong> the right drug for acute, performance-related anxiety (flying, public speaking, exams) — for those use cases beta-blockers (propranolol), benzodiazepines, or hydroxyzine are clinically appropriate. If you do not have a diagnosed mood, anxiety, or psychiatric disorder, do not start this medication.<\/div>\n
FDA black-box warning — suicidality.<\/strong> All antidepressants carry an FDA black-box warning for increased risk of suicidal thinking and behaviour in children, adolescents, and young adults under 25, particularly during the first weeks of treatment or after dose changes. Family members and prescribers should monitor closely for worsening mood, agitation, or suicidal ideation in this age group.<\/div>\n

What Is Vilano?<\/h2>\n

Vilano is an oral tablet of vilazodone hydrochloride 40 mg<\/strong> manufactured by Lupin Pharmaceuticals. Vilazodone (US brand Viibryd<\/strong>) was FDA-approved in 2011 as a dual-mechanism antidepressant: it combines selective serotonin reuptake inhibition (SSRI) with 5-HT1A<\/sub> partial agonism<\/strong>, similar to the partial agonism of buspirone. The 5-HT1A<\/sub> partial agonism is proposed to reduce the sexual side-effect burden seen with classical SSRIs.<\/p>\n

J\u00f3v\u00e1hagyott indik\u00e1ci\u00f3k<\/h2>\n